Editorial illustration of RFK Jr., the Capitol, and an MMR vial beside the words “Measles is back. RFK Jr. owes America answers.”

Measles Is Back. RFK Jr. Owes America More Than Excuses.

By JT Santana | jtwb768

America did not need another lesson in what happens when political grievance is allowed to substitute for public health. We had the vaccine, the medical knowledge, and decades of experience controlling measles. We had an achievement worth protecting: the elimination of sustained domestic transmission of a disease capable of causing pneumonia, brain inflammation, and death. What we needed was leadership committed to preserving that protection. What we received from Robert F. Kennedy Jr. was a federal vaccination agenda that treated confidence in established medicine as something to dismantle and renegotiate.

On November 17, 2026, international health officials announced that the United States had lost its measles elimination status. The designation had stood since 2000. Its loss marks the return of sustained transmission, rather than the occasional imported infection followed by a contained outbreak (Associated Press, 2026). This is a public health failure with consequences far beyond an embarrassing headline. 

The Centers for Disease Control and Prevention recorded 5,412 confirmed measles cases in 2026 through November 12. Its historical data place that total above every annual count since 1991. Those are preliminary figures, but the direction is unmistakable: a disease that the United States had brought under control has regained ground (Centers for Disease Control and Prevention [CDC], 2026a). 

Kennedy did not invent vaccine misinformation, and the decline in vaccination did not begin with his appointment. Any honest account must acknowledge that history. Yet inheriting a dangerous situation does not excuse worsening it. A health secretary confronting falling vaccine confidence has a responsibility to strengthen evidence, improve access, and communicate clearly. Kennedy’s record gives Americans ample reason to conclude that he has failed that responsibility.

My argument is not that one official personally caused every infection. No credible analysis can assign every measles case to a particular speech, appointment, or administrative decision. My argument is that Kennedy bears substantial political responsibility for a federal response that has undermined the confidence and institutional stability needed to stop an already growing crisis. His changes to vaccination governance, his administration’s assault on established vaccination practices, and his conflicting messages deserve scrutiny proportionate to the stakes.

There is no need to invent a vaccine ban to make that case. The documented record is damning enough. Public health does not require a formal prohibition on vaccination to deteriorate; it can deteriorate when the people responsible for protecting it make reliable advice harder to recognize, harder to trust, and harder to act upon.

An Existing Crisis Is a Responsibility, Not an Alibi

The most convenient defense of Kennedy is that vaccination rates were falling before he became health secretary. That statement is true. The conclusion his defenders would like us to draw—that his leadership cannot be held responsible for what followed—is not.

CDC data show that kindergarten MMR coverage fell from 95.2 percent in the 2019–2020 school year to 92.4 percent in 2025–2026. The latest school vaccination report identifies approximately 280,000 kindergartners without documentation of completing the MMR series. Exemptions from at least one required vaccine reached 4.2 percent, up from 3.6 percent the previous year (CDC, 2026a, 2026b). These figures describe a problem developing across administrations, with continuing deterioration during Kennedy’s tenure. 

That timeline should discipline the criticism, not extinguish it. We should not pretend that an executive action in 2026 produced a vaccination gap established years earlier. We should ask what the administration did after it encountered that gap. Did it make preventive care easier to obtain? Did it give clinicians consistent support? Did it present established evidence clearly, or turn the vaccination schedule into another arena for ideological confrontation?

An inherited weakness makes responsible leadership more urgent. A health secretary does not receive a grace period during which public statements have no consequences and institutional disruption counts as harmless experimentation. The job exists precisely to confront threats that are already present. Announcing that the threat predates the appointment answers a chronological question; it does not answer a question about competence.

The same distinction applies to outbreaks abroad. Measles circulating in other countries creates opportunities for infections to reach the United States. It does not explain away the domestic conditions that allow transmission to persist. International exposure and domestic vulnerability are separate parts of the problem, and a serious response must address both.

There is a further problem with using history as Kennedy’s defense. Longstanding vaccine distrust is the very condition that should have made federal officials more careful about sowing fresh uncertainty. A public already struggling to distinguish credible advice from manipulative claims needs clarity from its health agencies. It does not need those agencies to stage their own public argument over whether established preventive practices deserve confidence.

Kennedy should be judged against the work the crisis demanded. A difficult starting point can explain why success takes effort, resources, and time. It cannot turn the deliberate destabilization of vaccination policy into a sound response. Americans are entitled to expect a health secretary to confront an existing danger without making the public’s task of avoiding it more difficult.

Kennedy Changed the Institutions Americans Depend On

On June 9, 2025, the Department of Health and Human Services announced that Kennedy had removed all 17 sitting members of the Advisory Committee on Immunization Practices. HHS presented the action as a means of restoring public trust. The announcement itself establishes the scale of the intervention: this was the wholesale replacement of the federal vaccine advisory panel, not a routine adjustment to its membership (U.S. Department of Health and Human Services [HHS], 2025). 

ACIP is part of the machinery through which medical evidence becomes practical advice. Its recommendations concern how vaccines should be used to control disease, and adopted recommendations become CDC policy. The committee’s work is not an abstract academic exercise; it helps shape the advice that reaches medical offices and families (CDC, 2025). 

No advisory committee deserves immunity from criticism. Conflicts of interest should be disclosed, procedures should be examined, and recommendations should change when reliable evidence warrants revision. Those principles are compatible with scientific independence. They do not require accepting the premise that replacing an entire panel at a secretary’s direction is proof of greater integrity.

The distinction is between accountability and political substitution. A credible reform identifies a documented problem, explains the remedy, and demonstrates how that remedy improves decision-making. Invoking public distrust does not complete that work. Distrust can be addressed through transparency, or it can be exploited to justify giving political leadership greater control over the institutions that are supposed to evaluate its claims.

The subsequent disruption was not merely rhetorical. The CDC’s current schedule page states that a March 16, 2026, preliminary court order stayed ACIP votes from its June, September, and December 2025 meetings and the January 5, 2026, memorandum revising the childhood schedule. The page identifies the July 2, 2025, schedule as the operative schedule under that order (CDC, n.d.-a). That is a procedural development, not a final judicial ruling on every vaccine controversy. It is still evidence of substantial instability in the administration’s attempted changes. 

Families should not need to follow federal litigation to determine whether a newly announced vaccination policy is in effect. Pediatric practices should not have to spend valuable appointment time explaining the difference between an announcement, a committee vote, a court order, and the schedule currently posted online. The public’s ability to act on medical advice depends partly on the clarity of the institutions issuing it.

I cannot calculate how many measles infections resulted from this institutional upheaval. Neither can anyone responsibly infer that number from the dismissal announcement alone. But the absence of a precise attributable case count does not make the governance failure imaginary. Kennedy chose disruption during a period when vaccination policy needed consistency, independence, and a coherent public explanation.

The MMR Recommendation Survived. The Attack on Confidence Did Too.

A forceful criticism must get the policy right. The administration’s January 5, 2026, announcement retained measles, mumps, and rubella among the diseases for which vaccination was recommended for all children. Trump’s August executive order retained them in that category, too (CDC, 2026c; Executive Order No. 14420, 2026). Claiming that Kennedy simply removed routine measles vaccination from the federal schedule would misrepresent the record. 

The actual policy deserves criticism on its own terms. The August 10 order called for MMR to be administered as three separate single-disease shots once those products became domestically available. It favored separate medical visits for childhood immunizations to the maximum feasible extent and directed HHS to develop options for individual vaccines, preserving access to combination products. Those provisions describe an announced policy direction and development work, not proof that separate MMR products were already available or universally replacing the combination vaccine (Executive Order No. 14420, 2026). 

There is a practical reason to question that direction. CDC clinical guidance explains that administering eligible vaccines at the same visit increases the likelihood of completing vaccination at the appropriate age. It cites a measles outbreak study in which approximately one-third of cases among unvaccinated, vaccine-eligible preschool children might have been prevented through MMR vaccination during visits when another vaccine was given (CDC, n.d.-b). Missed opportunities are an established public health concern. 

Consider a parent who must arrange transportation, secure time away from work, and find care for another child to attend an appointment. Each extra visit can introduce another practical obstacle. That example does not establish that every family will miss a visit, or that every proposed scheduling change will produce harm. It illustrates why a recommendation for additional appointments needs evidence of a benefit sufficient to justify those burdens.

The message conveyed by the proposal deserves equal attention. Telling families that an established combination vaccine should eventually be separated can imply that the existing product is a compromise they ought to question. My concern is that some parents may interpret a promised future alternative as a reason to postpone protection now. That is a foreseeable communication risk, not a measured estimate of infections caused by the order.

A responsible administration would have to confront that risk directly. It would explain the evidence for the proposed change, the consequences of delay, and the status of products actually available. Rebranding a vaccination policy does not establish its medical superiority. During a measles resurgence, the standard should be whether a change improves timely protection, not whether it satisfies a political movement’s suspicions.

Manufactured Doubt Is Not Scientific Rigor

The controversy over vaccination has long depended on a rhetorical trick: treating the existence of a question as proof that the evidence remains evenly divided. A claim can survive politically long after serious research has failed to support it. Repeating the question then becomes a way to preserve suspicion without accepting the burden of demonstrating that suspicion is justified.

The MMR-autism claim is a clear example. A nationwide Danish cohort study followed 657,461 children and found no increased autism risk associated with MMR vaccination. Its analysis did not support the claim that vaccination triggered autism in susceptible children or produced clustering after vaccination (Hviid et al., 2019). That is substantive evidence, not a slogan offered in place of research. 

The World Health Organization’s vaccine safety committee reviewed further evidence in 2025 and reaffirmed that the available high-quality evidence does not support a causal relationship between vaccines and autism. Its assessment distinguished stronger studies from reports with serious methodological limitations. That distinction is the work of science: evaluating the quality of evidence rather than counting every allegation as an equally credible contribution (World Health Organization [WHO], 2025). 

Scientific caution does not mean that every hypothetical deserves permanent control over public policy. No medical intervention comes with an intellectually honest promise of absolute, universal, zero risk. The relevant questions concern demonstrated benefits, documented harms, the quality of the supporting evidence, and the risks of leaving people unprotected. A demand for impossible certainty can become an excuse to disregard substantial knowledge.

This is where political messaging can distort the entire discussion. Officials can present themselves as brave questioners without specifying what findings would satisfy them. They can demand more research indefinitely, then treat the continued existence of research as evidence that previous recommendations were premature. Under that standard, knowledge never becomes actionable; only doubt becomes permanent.

Parents deserve better than that performance. They deserve information about genuine adverse reactions, medical contraindications, and the evidence supporting a recommendation. They deserve an answer that neither conceals uncertainty nor exaggerates it. Turning a disproven or unsupported allegation into an enduring public spectacle does not respect parental judgment. It makes the information available to parents less reliable.

Autistic people deserve better, too. They should not be reduced to a frightening outcome in somebody else’s vaccination argument. Rejecting an unsupported claim about causation is compatible with demanding better services, better research, and greater respect for autistic lives. Public health leadership should be capable of doing both without using one community to frighten another.

An Occasional Endorsement Cannot Repair a Conflicting Message

Kennedy’s defenders can point to statements in which he supported measles vaccination. They are entitled to do so. AP reports that Kennedy and CDC leadership have described vaccination as the best way to prevent measles, and that the CDC awarded $100 million for state and local measles response in August and September (Associated Press, 2026). An honest assessment must acknowledge those actions. 

Those facts do not settle the question of whether his overall leadership helped or hindered the response. A Reuters investigation published November 17 describes conflicting Kennedy statements, pressure against established vaccination policy, and weakened outbreak capacity. In Utah, it reported that federal funding cuts forced the loss of more than three dozen public health workers. HHS defended its response and said it had consistently recommended vaccination as the most effective prevention measure (Reuters, 2026). 

The Utah example is significant without being stretched into a complete national explanation. An outbreak response depends on people who investigate cases, identify contacts, explain exposures, coordinate clinics, and answer worried families. Funding and staffing decisions affect the capacity to perform that work. A press release endorsing vaccination does not perform it.

Nor does an isolated endorsement cancel the implications of other messages. The public encounters leadership through interviews, announcements, political appearances, agency changes, and statements repeated by supporters. A secretary’s influence cannot be evaluated by selecting the most reassuring sentence and excluding the rest of his record. Consistency is part of the intervention.

There is a difference between a medical recommendation and a public campaign capable of supporting it. The recommendation can remain technically intact as the surrounding conversation makes it appear suspect. Families may hear that vaccination is available, yet encounter repeated official signals that the system recommending it cannot be trusted. It is reasonable to scrutinize that contradiction without pretending to know the private reasoning of every parent.

The standard for a health secretary should be demanding. He should make evidence easier to interpret, support the staff responsible for outbreak control, and correct misleading statements with the same visibility given to the original claims. He should not expect gratitude for occasionally affirming the prevention tool his own agencies continue to recommend.

My judgment is that Kennedy’s record fails that standard. The issue is not whether he has ever uttered a medically sound sentence. The issue is whether his administration has provided a coherent, adequately supported response to a predictable danger. A collection of favorable quotations cannot substitute for that assessment.

The People Carrying the Risk Did Not All Choose It

Political arguments about vaccination frequently stop at the parent making a decision. Infectious disease does not stop there. A decision affecting susceptibility can have consequences for people who did not participate in it, did not endorse it, and may have limited ability to protect themselves.

CDC guidance identifies young children, pregnant people, adults over 20, and people with weakened immune systems as groups at greater risk of severe measles complications. It describes airborne transmission and the possibility of exposure in a room up to two hours after an infected person has left. Two MMR doses provide approximately 97 percent protection against measles; serious vaccine reactions are extremely rare (CDC, n.d.-c). Those facts explain why community protection cannot be reduced to a private consumer preference. 

Consider three ordinary settings: a waiting room containing a medically vulnerable patient, a household caring for an infant, and a school where a child’s medical circumstances limit vaccination options. These are illustrative situations, not accounts of identified patients. Each exposes the weakness in the claim that the consequences of vaccination decisions belong exclusively to the person making them.

The patient in the waiting room cannot inspect the vaccination history of everyone who occupied the space earlier. The infant cannot choose an earlier birthday to become eligible for routine vaccination. The medically vulnerable child cannot negotiate individual agreements with every household connected to the school. Their safety depends partly on decisions made beyond their reach.

Measles can leave consequences beyond the initial illness. CDC describes immune amnesia, a disruption of immune memory that can make a person more susceptible to other infections for months or years. The severity varies, but the phenomenon is another reason to reject sentimental portrayals of measles as a harmless childhood milestone (CDC, n.d.-d). Surviving the rash does not necessarily mean escaping every consequence. 

None of this justifies treating every worried parent as malicious. Some families encounter transportation barriers, fragmented care, confusing records, or persuasive misinformation. Anger directed indiscriminately at those families can obscure the people with the greatest institutional responsibility. Officials who control federal messaging and vaccination policy occupy a different position from a parent trying to sort through conflicting claims.

That difference is why Kennedy deserves concentrated scrutiny. His office carries resources, visibility, and access to expertise unavailable to most households. He has a duty to use those advantages responsibly. The people facing the consequences of preventable exposure should not have to accept ideological experimentation as the price of somebody else’s political project.

Accountability Requires More Than Changing the Headline

Regaining control will require work that is less theatrical than announcing a new vaccination philosophy. It will require accessible appointments, functioning surveillance, stable staffing, clear communication, and sustained cooperation with communities. Those are ordinary public health responsibilities. Their familiarity does not make them optional.

Congress should demand a documented account of the administration’s decisions. Which vaccination initiatives were reduced, maintained, or strengthened? What happened to outbreak-response staffing after funding changes? What evidence supported proposed alterations to established vaccination practices, and how were their likely effects on timely vaccination assessed? These are answerable oversight questions, not invitations to repeat campaign language.

The same scrutiny should apply to communication. Officials should explain how they evaluated the possible effects of contradictory statements on vaccine confidence. They should identify what steps they took to correct misleading impressions and provide evidence that those corrections reached the relevant audiences. Announcing that a message was technically available somewhere on a government website is not an adequate account of public communication.

Medical independence needs protection as well. Advisory bodies should be subject to clear conflict rules, transparent procedures, and meaningful scientific review. Their legitimacy should not depend on whether their conclusions flatter the secretary who appoints them. A system that can scrutinize manufacturers must be able to scrutinize political leadership with equal seriousness.

The public deserves measurable goals. A credible recovery effort would identify gaps in vaccination, specify the resources assigned to closing them, and report progress in a form communities can evaluate. It would distinguish completed actions from proposals and actual improvements from promotional claims. Responsibility becomes harder to evade when promises have dates, resources, and observable results attached to them.

I do not need to claim that Kennedy caused every case to conclude that his leadership has been unacceptable. I do not need to erase earlier vaccination declines to judge the choices he made after taking office. And I do not need to pretend that measles vaccination disappeared from the schedule to recognize the harm that political attacks on medical credibility can invite.

Kennedy owes the country a clear reversal of the practices that have made reliable vaccination advice harder to sustain. He owes health workers support, families accurate information, and Congress a record that can withstand scrutiny. If he cannot provide those things without returning to the suspicions that have defined his public approach to vaccination, he should leave the office.

The United States lost something that took years of collective effort to achieve. Recovering it will require leaders willing to defend effective prevention without turning every established fact into a political bargaining chip. America does not need another performance about medical freedom from the official charged with protecting its health. It needs fewer preventable infections, stronger public institutions, and a health secretary willing to be judged by those results.

References

Associated Press. (2026, November 17). Measles is no longer considered eliminated in the US and Mexico.⁠

Centers for Disease Control and Prevention. (2025, August 8). ACIP recommendations.⁠

Centers for Disease Control and Prevention. (2026a). Measles cases and outbreaks.⁠ Data through November 12, 2026.

Centers for Disease Control and Prevention. (2026b). Vaccination coverage and exemptions among kindergartners.⁠

Centers for Disease Control and Prevention. (2026c, January 5). CDC acts on presidential memorandum to update childhood immunization schedule.⁠

Centers for Disease Control and Prevention. (n.d.-a). Vaccines and other immunizing agents in the child and adolescent immunization schedule.⁠ Retrieved November 17, 2026.

Centers for Disease Control and Prevention. (n.d.-b). Timing and spacing of immunobiologics.⁠

Centers for Disease Control and Prevention. (n.d.-c). About measles.⁠

Centers for Disease Control and Prevention. (n.d.-d). Questions about measles.⁠

Executive Order No. 14420, 91 Fed. Reg. 53173 (2026, August 14). Delivering gold standard childhood vaccine recommendations for Americans.⁠

Hviid, A., Hansen, J. V., Frisch, M., & Melbye, M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513–520. https://doi.org/10.7326/M18-2101⁠

Reuters. (2026, November 17). How Kennedy let measles run wild in America.⁠

U.S. Department of Health and Human Services. (2025, June 9). HHS takes bold step to restore public trust in vaccines by reconstituting ACIP.⁠

World Health Organization. (2025, December 11). Statement of the WHO Global Advisory Committee on Vaccine Safety on vaccines and autism.⁠

Promotional graphic for JTWB768.com featuring a purple zebra logo and text describing the website as the digital home of writer and advocate JT Santana, focused on LGBTQ+ issues, disability, mental health, public policy, social justice, and human experiences, with the tagline “Stories. Research. Justice. Humanity. No topic is off-limits.”

Leave a Reply